گروه دارویی سبحان
دسبحا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 8,310 1.19
Close Price: 8,450
Financial Ratios
AGM
Interim
2026/06/22 Fiscal Year 2026/03/2012 Month | 2025/05/26 Fiscal Year 2025/03/2012 Month | 2024/06/20 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 110.43 | 248.39 | 126.4 | |
Gross Profit to Sales | 110.43 | 248.39 | 126.4 | |
Operating Margin | 86.8 | 86.53 | 97.42 | |
Gross Profit to Sales | 100 | 100 | 100 | |
Net Profit to Gross Profit | 110.43 | 248.39 | 126.4 | |
Return on Assets (ROA) | 11.37 | 13.42 | 32.37 | |
Return on Capital (%) | 20.34 | 49.48 | 105.89 | |
Return on Equity (ROE) | 13.32 | 20.14 | 41.26 | |
Working Capital Return | 124.39 | -254.77 | 134.47 | |
Fixed Asset Return | 613.91 | 409,396.68 | 738,596 | |
Loan Benefit Assessment | 1.17 | 1.5 | 1.27 | |
Current Ratio | 1.63 | 0.84 | 2.12 | |
Quick Ratio | 1.63 | 0.84 | 2.12 | |
Liquidity Ratio | 0.18 | 0.04 | 0.08 | |
Net Working Capital | 2,374,014 | -1,354,614 | 5,492,541 | |
Current Assets Ratio | 0.24 | 0.28 | 0.46 | |
Receivables Collection Period | 746.41 | 1,806.82 | 624.75 | |
Inventory to Working Capital | 0 | - | - | |
Working Capital Turnover | 1.13 | -1.03 | 1.06 | |
Fixed Asset Turnover | 5.56 | 1,648.17 | 5,843.18 | |
Total Asset Turnover | 0.1 | 0.05 | 0.26 | |
Debt Ratio | 0.15 | 0.33 | 0.22 | |
Debt to Equity | 0.17 | 0.5 | 0.27 | |
Long-Term Debt to Equity | 0 | 0 | 0 | |
Current Debt to Equity | 0.17 | 0.5 | 0.27 | |
Equity Ratio | 85.39 | 66.63 | 78.47 | |
Debt Coverage Ratio | 45.16 | 0.06 | 0.08 |